LUMICKS launches Avidion to improve cell therapy development
Avidion brings clarity to immune drug-tumor interactions, helping scientists identify better cell therapy candidates, understand mechanisms, and advance with confidence.... Read more.
Transparency in Action: CoinEx Confirms 100% Reserve in September 2025
HONG KONG, Sept. 9, 2025 /PRNewswire/ — In the world of cryptocurrency exchanges, Proof of Reserve is one of the most important measures of transparency... Read more.
MINISFORUM’s AI-Powered N5 Pro Wins AI Storage Technology Innovation Award at IFA 2025
BERLIN, Sept. 9, 2025 /PRNewswire/ — MINISFORUM, a global innovator in compact computing solutions, its AI-powered N5 Pro has been awarded the AI Storage... Read more.
Xinhua Silk Road: Conference held in NE. China’s Shenyang to boost high-quality development of global industrial economy
BEIJING, Sept. 9, 2025 /PRNewswire/ — The 2025 Exchange Conference on Global Industrial Internet Integrated Development, themed “Intelligent Industry... Read more.
Thunes Launches Real-Time Payments into Morocco
Members of Thunes’ Direct Global Network can now offer real-time payments to bank accounts in Morocco, meeting consumer demand for faster cross-border... Read more.
Global hydrogen industry surpasses USD 110 billion in committed investment as 500+ projects worldwide reach maturity
MILAN and BRUSSELS, Sept. 9, 2025 /PRNewswire/ — The clean hydrogen sector has reached a major milestone, with USD 110 billion in investment now committed... Read more.
ROHM Has Developed Ultra-compact CMOS Op Amp: Delivering Industry-leading Ultra-low Circuit Current
KYOTO, Japan, Sept. 9, 2025 /PRNewswire/ — ROHM Co., Ltd. has announced that its ultra-compact CMOS Operational Amplifier (op amp) TLR1901GXZ achieves... Read more.
iOnctura Expands Roginolisib Trials to the US, Advancing Multi-Indication Strategy in Oncology
US cancer centers begin enrolling patients into the global, randomized Phase II study of roginolisib in metastatic uveal melanoma Dana-Farber Cancer Institute launches... Read more.
Sumsub AI Academic Program: First-of-its-kind Partnership with Constructor University to Combat Deepfake Fraud
Collaboration between a global verification and anti-fraud leader and renowned German university advancing research and education to tackle AI-powered digital fraud... Read more.
Alchemab Therapeutics initiates Phase 1 clinical trial of ATLX-1282 and announces Series A financing extension
– Follows successful completion of pre-clinical activities by Alchemab as part of earlier licensing deal with Eli Lilly and Company for ATLX-1282 ... Read more.